Search

Your search keyword '"Cuman, Magdalena"' showing total 39 results
Start Over Author "Cuman, Magdalena"
39 results on '"Cuman, Magdalena"'

1. Development of Weight and Height Age z-Score after Total Cavopulmonary Connection.

Author

Bilic, Carlo, Staehler, Helena, Niedermaier, Carolin, Schaeffer, Thibault, Cuman, Magdalena, Heinisch, Paul Philipp, Burri, Melchior, Piber, Nicole, Hager, Alfred, Ewert, Peter, Hörer, Jürgen, and Ono, Masamichi

Subjects
HYPOPLASTIC left heart syndrome, ODDS ratio
Abstract

Objective We aimed to analyze somatic growth of patients after total cavopulmonary connection (TCPC) as well as to identify factors influencing postoperative catch-up growth. Methods A total of 309 patients undergoing TCPC at 4 years old or less between 1994 and 2021 were included. Weight for age z-score (WAZ) and height for age-z-score (HAZ) at TCPC and at postoperative time between 1 and 3 years were calculated. Factors influencing somatic growth were analyzed. Results Most frequent diagnosis and initial palliation were hypoplastic left heart syndrome (HLHS) (34%) and the Norwood procedure (51%), respectively. Median age and weight at TCPC were 2.0 (IQR: 1.7–2.5) years and 11.3 (10.5–12.7) kg, respectively. Median 519 days after TCPC, a significant increase in WAZ (−0.4 to −0.2, p < 0.001) was observed, but not in HAZ (−0.6 to −0.6, p = 0.38). Older age at TCPC (p < 0.001, odds ratio [OR]: 2.6) and HLHS (p = 0.007, OR: 2.2) were risks for low WAZ after TCPC. Older age at TCPC (p = 0.009, OR: 1.9) and previous Norwood procedure (p = 0.021, OR: 2.0) were risks for low HAZ after TCPC. Previous bidirectional cavopulmonary shunt (BCPS) was a protective factor for both WAZ (p = 0.012, OR: 0.06) and HAZ (p = 0.028, OR: 0.30) at TCPC. Conclusion In patients undergoing TCPC at the age of 4 years or less, a significant catch-up growth was observed in WAZ after TCPC, but not in HAZ. Previous BCPS resulted to be a protective factor for a better somatic development at TCPC. HLHSs undergoing Norwood were considered as risks for somatic development after TCPC. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Mid-Term Electrical Remodeling after Percutaneous Atrial Septal Defect Closure with GCO Device in a Pediatric Population

Author

Fumanelli, Jennifer, primary, Garibaldi, Silvia, additional, Castaldi, Biagio, additional, Di Candia, Angela, additional, Pizzuto, Alessandra, additional, Sirico, Domenico, additional, Cuman, Magdalena, additional, Mirizzi, Gianluca, additional, Marchese, Pietro, additional, Cantinotti, Massimiliano, additional, Piacenti, Marcello, additional, Assanta, Nadia, additional, Viacava, Cecilia, additional, Di Salvo, Giovanni, additional, and Santoro, Giuseppe, additional

Published
2023
Full Text
View/download PDF

9. Development of Weight and Height Age z-Score after Total Cavopulmonary Connection

Author

Bilic, Carlo, additional, Staehler, Helena, additional, Niedermaier, Carolin, additional, Schaeffer, Thibault, additional, Cuman, Magdalena, additional, Heinisch, Paul Philipp, additional, Burri, Melchior, additional, Piber, Nicole, additional, Hager, Alfred, additional, Ewert, Peter, additional, Hörer, Jürgen, additional, and Ono, Masamichi, additional

Published
2023
Full Text
View/download PDF

25. Cardiac CT angiography: normal and pathological anatomical features—a narrative review

Author

Clemente, Alberto, primary, Seitun, Sara, additional, Mantini, Cesare, additional, Gentile, Giovanni, additional, Federici, Duccio, additional, Barison, Andrea, additional, Rossi, Andrea, additional, Cuman, Magdalena, additional, Pizzuto, Alessandra, additional, Ait-Ali, Lamia, additional, Bossone, Eduardo, additional, Cademartiri, Filippo, additional, and Chiappino, Dante, additional

Published
2020
Full Text
View/download PDF

31. Rescue atrial septal defect closure with the new GORE® cardioform atrial septal defect occluder.

Author

Pizzuto, Alessandra, Cuman, Magdalena, Cantinotti, Massimiliano, Franchi, Eliana, Corana, Giulia, Viacava, Cecilia, Assanta, Nadia, and Santoro, Giuseppe

Subjects
*ATRIAL septal defects, *HEART block, *TREATMENT effectiveness, *ADVERSE health care events, *VASCULAR closure devices
Abstract

Atrioventricular block (AVB) is an infrequent but life-threatening complication of transcatheter closure of atrial septal defect (ASD), accounting for 0.1%--6.2% of cases in large series. It has been related to unfavorable defect anatomy as well as size and intrinsic stiffness of the occluding device. In this setting, the new GORE® cardioform ASD occluder (GCA) device could be an appealing technical advance in ASD treatment. We report a case of complete AVB after ASD closure with an Amplatzer septal occluding (Abbott, Plymouth MN, USA) device successfully treated by its percutaneous retrieval and "rescue" deployment of GCA device few months later. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

38. [Epidemiology of stroke and cerebral protection in patients undergoing transcatheter aortic valve replacement].

Author

Testa L, Pero G, Bollati M, Casenghi M, Popolo Rubbio A, Cuman M, Agnifili M, Pizzocri S, and Bedogni F

Subjects
Humans, Incidence, Quality of Life, Risk Factors, Stroke epidemiology, Stroke etiology, Transcatheter Aortic Valve Replacement adverse effects, Aortic Valve Stenosis surgery, Stroke prevention & control, Transcatheter Aortic Valve Replacement methods
Abstract

The introduction into clinical practice of transcatheter aortic valve implantation (TAVI) has led to a significant change in the therapeutic paradigm for patients with valvular aortic stenosis. However, in parallel with the benefits obtained in prognosis and quality of life, an inherent risk of major cerebral thromboembolic events has been observed. In different studies this risk has been estimated between 2% and 6%. In order to reduce the incidence of cerebrovascular accidents during TAVI, several brain protection systems have been developed but, to date, none has obtained sufficient clinical evidence to be implemented on a large scale, and they are therefore used only in selected cases. Furthermore, periprocedural drug therapy and follow-up are still the subject of extensive discussion in the scientific community. This paper reviews the topic of stroke prevention in patients undergoing TAVI for both the periprocedural and postprocedural aspects.

Published
2019
Full Text
View/download PDF

39. Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population.

Author

Maggio S, Zanetti C, Pesarini G, Zivelonghi C, Piccoli A, Gambaro A, Scarsini R, Cuman M, Vassanelli C, and Ribichini F

Subjects
Acute Coronary Syndrome mortality, Acute Coronary Syndrome surgery, Adult, Aged, Blood Vessel Prosthesis Implantation mortality, Female, Follow-Up Studies, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Postoperative Complications epidemiology, Postoperative Complications mortality, Prospective Studies, Registries, Treatment Outcome, Absorbable Implants, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation methods, Endovascular Procedures statistics & numerical data, Tissue Scaffolds
Abstract

Background: The aim of this study was to evaluate the safety and efficacy of bioresorbable vascular scaffolds (BVS) in terms of acute success and long-term clinical events in a real world population according to the most updated technical recommendations., Methods: Perspective, single-center registry involving symptomatic patients treated with BVS from February 2013 to January 2016. Primary end-point was the occurrence of MACCEs at one year: death, target vessel related myocardial infarction, target vessel revascularization, stroke, major bleeding. Secondary endpoints were acute device and procedural clinical success, and occurrence of MACCEs at long-term follow-up., Results: In total, 112 patients were treated on 173 lesions. Average age was 55.53±12.4 years and acute coronary syndrome was the admission diagnosis for 79.5% patients. Nine patients presented cardiac allograft vasculopathy after cardiac transplantation. Multi-vessel disease was treated in 50% of cases. Predilatation and post-dilatation were performed respectively in 96% and 88.4% of lesions. Intravascular imaging was used in 41 patients (37%). Angiographic success rate and procedural success rate were 100% and 97.3% respectively. Clinical follow-up was completed in 100 patients with an average follow-up of 10.5±8.3 months. Including peri-procedural and in-hospital MACCEs, target vessel failure was noticed in 7% of patients in the first year of follow up and in 11% of patients at long-term follow-up. Two cases of target lesion revascularization occurred 25 and 26 months after the index procedure. No cases of definite stent thrombosis were reported., Conclusions: Strict adherence to expert recommendation for BVS placement may minimize device related peri-procedural and mid-to-long term MACCEs in a real world population.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results